Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

NCT05917587 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

NCT NCT05917587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05917587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
September 11, 2024
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes